CHALLENGES IN THE TREATMENT OF ACUTE FULMINANT HEPATITIS B: Case Report and Literature Review.
J Med Liban
; 63(2): 102-6, 2015.
Article
en En
| MEDLINE
| ID: mdl-26164980
Acute hepatitis B is a serious cause of fulminant hepatic failure and subsequent mortality. No established guidelines are currently present for the treatment of this life threatening entity. Several therapeutic options were reported in the literature including the use of lamivudine as well as the more novel nucleoside analogue entecavir. We report an unfortunate case of fulminant hepatitis B that passed away despite intensive care unit management and treatment with entecavir in combination with steroids. Extensive review of the literature about various therapeutic approaches to manage fulminant hepatitis B was conducted. The aim of this report is to emphasize the need for larger more structured studies in order to improve the outcome of the treatment of this entity.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fallo Hepático Agudo
/
Hepatitis B
Tipo de estudio:
Guideline
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Med Liban
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Líbano